SPECIAL NOTICE
66 -- Maintenance agreement for genechip system
- Notice Date
- 10/5/2010
- Notice Type
- Special Notice
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, IRP, 9000 Rockville Pike, Room 1B59, Bethesda, Maryland, 20892
- ZIP Code
- 20892
- Solicitation Number
- NIHDA2011101
- Archive Date
- 10/30/2010
- Point of Contact
- John Johnson, Phone: 4437402449
- E-Mail Address
-
johnsonjr@mail.nih.gov
(johnsonjr@mail.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- This is a notice of intent, not a request for a proposal. A solicitation document will not be issued and proposals will not be requested. The National Institute on Drug Abuse (NIDA), Intramural Research Program (IRP) intends to solicit, negotiate and award a purchase order on a noncompetitive basis with Affymetrix, Inc., 3420 Central Expressway, Santa Clara, CA 95051. National Institutes on Drug Abuse (NIDA), Division of Intramural Research in Baltimore, Maryland requires maintenance on models: #GCS (S/N #74900234), 640 (S/N #12386), FS450U (S/N #FS0290), WS-SYS (S/N #F4RLFG1), GC30007G (S/N #50209150, AUTOLOADER (S/N #A13720), and FS3450 (S/N #60123080. Affymetrix is producing gene arrays that contain 1,000,000 SNPs (single nucleotide polymorphisms), the only arrays commercially available at that density. Analysis of SNP's in the human genome is crucial to our studies of drug abuse vulnerability loci. This gets close to reasonable power for detection of most of the addiction vulnerability loci in our samples, according to our modeling. The addition of this approach to our ongoing studies will put us in the forefront of drug abuse related genetic research. In accordance with FAR6.302-1, the supplies required by the agency are available from only one responsible source, Affymetrix, Inc. and no other supplier will satisfy the agency requirements. There are no licensed systems or instruments offered by third party providers that are able to use any components of the Affymetrix, Gene Chip System, including arrays. The highest SNP density commercially available is needed to identify drug abuse vulnerability loci and prove or disprove the idea of polygenic contributions of common allelic variants to drug abuse vulnerability. The acquisition is being conducted under simplified acquisition FAR 13 and is exempt from the requirements of FAR Part 6, Competition Requirement. This notice of intent is not a request for competitive proposals. Interested parties may identify their interest and capabilities in response to this synopsis. The determination by the Government not to compete the proposed contract based upon responses to this notice is solely with the discretion of the Government. Comments to this announcement, referencing notification number NIHDA2011101must be submitted by October 15, 2010 to NIH, NIDA, IRP, 251 Bayview Boulevard, Suite 200, BRC Bldg., Rm 04A326, Baltimore, MD 21224, ATTN: John Johnson.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIDA/NIHDA2011101/listing.html)
- Place of Performance
- Address: NIH/NIDA/IRP, 251 Bayview Blvd STE 200, Baltimore, Maryland, 21224, United States
- Zip Code: 21224
- Zip Code: 21224
- Record
- SN02306312-W 20101007/101005234527-a209454e45b7cc7293046ee7c25a7132 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |